Your browser doesn't support javascript.
loading
Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM study.
Bader, Peter; Pötschger, Ulrike; Dalle, Jean-Hugues; Moser, Laura M; Balduzzi, Adriana; Ansari, Marc; Buechner, Jochen; Güngör, Tayfun; Ifversen, Marianne; Krivan, Gergely; Pichler, Herbert; Renard, Marleen; Staciuk, Raquel; Sedlacek, Petr; Stein, Jerry; Heusel, Jan Robert; Truong, Tony; Wachowiak, Jacek; Yesilipek, Akif; Locatelli, Franco; Peters, Christina.
Afiliação
  • Bader P; Goethe University, University Hospital, Department of Pediatrics, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Frankfurt, Germany.
  • Pötschger U; St. Anna Children's Cancer Research Institute, Vienna, Austria.
  • Dalle JH; Pediatric Hematology and Immunology Department, Robert Debré Hospital, Groupe Hospitalo-Universitaire Assistance Publique Hôpitaux de Paris (GHU AP-HP) Nord, Université Paris Cité, Paris, France.
  • Moser LM; Goethe University, University Hospital, Department of Pediatrics, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Frankfurt, Germany.
  • Balduzzi A; Università degli Studi di Milano-Fondazione, FONDAZIONE MONZA E BRIANZA PER IL BAMBINO E LA SUA MAMMA (MBBM), Department for Pediatric Hematology and Oncology, Monza, Italy.
  • Ansari M; CANSEARCH Research Platform for Pediatric Oncology and Hematology, Faculty of Medicine, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Switzerland.
  • Buechner J; Division of Pediatric Oncology and Hematology, Department of Women, Child and Adolescent, University Geneva Hospitals, Geneva, Switzerland.
  • Güngör T; Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.
  • Ifversen M; Department of Hematology/Oncology/Immunology, Gene Therapy, and Stem Cell Transplantation, University Children's Hospital Zürich, Eleonore Foundation & Children's Research Center, Zürich, Switzerland.
  • Krivan G; Copenhagen University Hospital Rigshospitalet, Department for Pediatric Hematology and Oncology, Copenhagen, Denmark.
  • Pichler H; Pediatric Hematology and Stem Cell Transplantation Department, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary.
  • Renard M; St. Anna Children's Hospital, University Vienna, Vienna, Austria.
  • Staciuk R; Department of Paediatric Oncology, University Hospital Leuven, Leuven, Belgium.
  • Sedlacek P; Hospital de Pediatría "Prof. Dr. Juan P. Garrahan," Buenos Aires, Buenos Aires, Argentina.
  • Stein J; Department of Pediatric Hematology and Oncology, Motol University Hospital, Prague, Czech Republic.
  • Heusel JR; Schneider Children's Medical Center of Israel and Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva, Israel.
  • Truong T; Goethe University, University Hospital, Department of Pediatrics, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Frankfurt, Germany.
  • Wachowiak J; Division of Pediatric Oncology and Cellular Therapy, Alberta Children's Hospital, Calgary, Alberta, Canada.
  • Yesilipek A; Department of Pediatric Oncology, Hematology and Transplantology, Poznan University of Medical Sciences, Poznan, Poland.
  • Locatelli F; Medical Park Antalya Hospital, Antalya, Turkey.
  • Peters C; Department of Pediatric Hematology and Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Italy.
Blood Adv ; 8(2): 416-428, 2024 01 23.
Article em En | MEDLINE | ID: mdl-37738088

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bussulfano / Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras / Doença Enxerto-Hospedeiro Limite: Child / Child, preschool / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bussulfano / Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras / Doença Enxerto-Hospedeiro Limite: Child / Child, preschool / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article